YTHDF1 is implicated in driving tumorigenesis, with elevated YTHDF1 linked to poor outcomes in several cancer types including hepatocellular carcinoma, colorectal cancer, and acute myeloid leukemia (6–9). Here, YTHDF1 is linked to hepatocellular carcinoma.